Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer
Kelsie L. Thu, David W. Cescon(Princess Margaret Hospital), Jennifer Silvester(Ontario Institute for Cancer Research), Jillian Haight(University Health Network), Asa P. Y. Lau(St. Michael's Hospital), Drew Wakeham(University Health Network), Chantal Tobin(University Health Network), I. Soria-Bretones(University Health Network), Soode Moghadas Jafari(Princess Margaret Cancer Centre), Kelsey Hodgson(University Health Network), Mark R. Bray(Princess Margaret Cancer Centre), Tessa Bray(University Health Network), Jennifer Cruickshank(Ontario Institute for Cancer Research)
Cited by 0
Related Papers
Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease
|Nature Genetics|2001|512
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
|Nature|2012|510
Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo
|The Journal of Experimental Medicine|2009|329
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
|Nature Communications|2020|307